Early-onset pathologically proven multiple system atrophy with LRRK2 G2019S mutation

Giulietta Maria Riboldi; Jose Alberto Palma; Etty Cortes; Megan A. Iida; Tamjeed Sikder; Brooklyn Henderson; Towfique Raj; Ruth H. Walker; John F. Crary; Horacio Kaufmann; Steven Frucht

doi:10.1002/mds.27710

Early-onset pathologically proven multiple system atrophy with LRRK2 G2019S mutation

Giulietta Maria Riboldi, Jose Alberto Palma, Etty Cortes, Megan A. Iida, Tamjeed Sikder, Brooklyn Henderson, Towfique Raj, Ruth H. Walker, John F. Crary, Horacio Kaufmann, Steven Frucht

Research output: Contribution to journal › Letter › peer-review

17 Scopus citations

Original language	English
Pages (from-to)	1080-1082
Number of pages	3
Journal	Movement Disorders
Volume	34
Issue number	7
DOIs	https://doi.org/10.1002/mds.27710
State	Published - Jul 2019

Access to Document

10.1002/mds.27710

Cite this

@article{9a6d98343a50413891e83f2782c8ae6d,

title = "Early-onset pathologically proven multiple system atrophy with LRRK2 G2019S mutation",

author = "Riboldi, {Giulietta Maria} and Palma, {Jose Alberto} and Etty Cortes and Iida, {Megan A.} and Tamjeed Sikder and Brooklyn Henderson and Towfique Raj and Walker, {Ruth H.} and Crary, {John F.} and Horacio Kaufmann and Steven Frucht",

note = "Funding Information: funding from the Michael J. Fox Foundation. J.F.C. has received funding from the NIH (R01-NS095252; R01-AG054008), Tau Consortium, and the Alzheimer{\textquoteright}s Association (NIRG-15-363188). H.K. has received funding from the NIH, Michael J. Fox Foundation, MSA Coalition, Familial Dysautonomia Foundation, and FDA; is an advisory board member for Lunbeck, Biogen, Theravance, Biohaven, Eli Lilly, Pfizer, and AstraZeneca; and is editor-in-chief of Funding Information: Funding agency: This study was supported by BrainEver. Funding Information: employee of Motac Neuroscience Ltd, a contract research organization. E.B. has an equity stake in Motac Holding Ltd and receives consultancy payments from Motac Neuroscience Ltd. Current grant support includes Agence Nationale de la Recherche (E.B.), China Science Fund (E.B.), Michael J Fox Foundation for Parkinson Research (E.B.), France Funding Information: agencies: National Institutes of Health (U54-NS065736-01) and the MSA Coalition.We acknowledge the staff at the Neuropathology Brain Bank & Research Core at Mount Sinai Hospital (New York) for technical support.",

year = "2019",

month = jul,

doi = "10.1002/mds.27710",

language = "English",

volume = "34",

pages = "1080--1082",

journal = "Movement Disorders",

issn = "0885-3185",

publisher = "John Wiley & Sons Inc.",

number = "7",

}

TY - JOUR

T1 - Early-onset pathologically proven multiple system atrophy with LRRK2 G2019S mutation

AU - Riboldi, Giulietta Maria

AU - Palma, Jose Alberto

AU - Cortes, Etty

AU - Iida, Megan A.

AU - Sikder, Tamjeed

AU - Henderson, Brooklyn

AU - Raj, Towfique

AU - Walker, Ruth H.

AU - Crary, John F.

AU - Kaufmann, Horacio

AU - Frucht, Steven

N1 - Funding Information: funding from the Michael J. Fox Foundation. J.F.C. has received funding from the NIH (R01-NS095252; R01-AG054008), Tau Consortium, and the Alzheimer’s Association (NIRG-15-363188). H.K. has received funding from the NIH, Michael J. Fox Foundation, MSA Coalition, Familial Dysautonomia Foundation, and FDA; is an advisory board member for Lunbeck, Biogen, Theravance, Biohaven, Eli Lilly, Pfizer, and AstraZeneca; and is editor-in-chief of Funding Information: Funding agency: This study was supported by BrainEver. Funding Information: employee of Motac Neuroscience Ltd, a contract research organization. E.B. has an equity stake in Motac Holding Ltd and receives consultancy payments from Motac Neuroscience Ltd. Current grant support includes Agence Nationale de la Recherche (E.B.), China Science Fund (E.B.), Michael J Fox Foundation for Parkinson Research (E.B.), France Funding Information: agencies: National Institutes of Health (U54-NS065736-01) and the MSA Coalition.We acknowledge the staff at the Neuropathology Brain Bank & Research Core at Mount Sinai Hospital (New York) for technical support.

PY - 2019/7

Y1 - 2019/7

UR - http://www.scopus.com/inward/record.url?scp=85065635916&partnerID=8YFLogxK

U2 - 10.1002/mds.27710

DO - 10.1002/mds.27710

M3 - Letter

C2 - 31077434

AN - SCOPUS:85065635916

SN - 0885-3185

VL - 34

SP - 1080

EP - 1082

JO - Movement Disorders

JF - Movement Disorders

IS - 7

ER -